Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy

Eur J Pediatr. 2001 Jun;160(6):401. doi: 10.1007/s004310100743.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Amantadine / adverse effects*
  • Amantadine / pharmacology
  • Amantadine / therapeutic use
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Brain Diseases / complications
  • Brain Diseases / drug therapy*
  • Dopamine Antagonists / adverse effects
  • Dopamine Antagonists / pharmacology
  • Humans
  • Influenza, Human / complications
  • Influenza, Human / drug therapy*
  • Male
  • Neuroleptic Malignant Syndrome / etiology*
  • Substance Withdrawal Syndrome* / etiology

Substances

  • Antiviral Agents
  • Dopamine Antagonists
  • Amantadine